ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - ampicillin as sodium 500 mg; sulbactam as sodium 250 mg - powder for solution for injection - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ampicillin as sodium; sulbactam as sodium - אבקה להכנת תמיסה לזריקה - ampicillin as sodium 1000 mg; sulbactam as sodium 500 mg - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ampicillin as sodium; sulbactam as sodium - אבקה להכנת תמיסה לזריקה - ampicillin as sodium 2000 mg; sulbactam as sodium 1000 mg - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 500 mg; clavulanic acid as potassium clavulanate 100 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as sodium; clavulanic acid as potassium clavulanate - אבקה להמסה להזרקה\אינפוזיה - amoxicillin as sodium 1000 mg; clavulanic acid as potassium clavulanate 200 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

taro international ltd - amoxicillin as sodium 1 g/vial; clavulanic acid as sodium 200 mg/vial - solution for injection - amoxicillin and enzyme inhibitor - clavamox is indicated for short-term treatment of bacterial infections caused by susceptible microorganisms which are resistant to other beta-lactamase antibiotics.

ישראל - עברית - Ministry of Health

vitamed pharmaceutical industries ltd - amoxicillin as trihydrate; clavulanic acid as potassium - תרחיף - clavulanic acid as potassium 62.5 mg / 5 ml; amoxicillin as trihydrate 250 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - lower respiratory infections, otitis media, sinusitis, acute pharyngitis, urinary tract infections, skin and soft tissue infections caused by beta-lactamase producing organisms susceptible to amoxycillin and clavulanic acid.

ישראל - עברית - Ministry of Health

zoetis israel holding b.v., israel - ceftiofur hydrochloride - תרחיף להזרקה - ceftiofur hydrochloride 50 mg / 1 ml

ישראל - עברית - Ministry of Health

romat ltd - cefquinome as sulfate - תרחיף להזרקה - cefquinome as sulfate 25 mg / 1 ml

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - ezetimibe 10 mg; simvastatin 10 mg - tablets - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh.patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).